Animal Health Discovery Services
Avista Pharma offers comprehensive animal health drug discovery services. Our state-of-the-art parasiticide platform supports the discovery and development of products for companion and production animals. The Avista bio-profiling portfolio includes over 30 species of clinically and commercially important ectoparasites (fleas, ticks, flies, mosquitos) and endoparasites (intestinal worms, heartworms), as well as protozoans (leishmania, cryptosporidium, trypanosomes). Avista has a proven record of success in the identification and optimization of anti-parasitics, with several candidates progressing into clinical studies and commercialization.